Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
FIR TREE CAPITAL MANAGEMENT LP OPA Magnum Opus Acquisition Limited 13G 6.92% 2y
Laurence Zuriff XMTR Xometry, Inc. 13G/A 7% 2y
ORBIMED ADVISORS LLC TARA Protara Therapeutics, Inc. 13G/A 0% 2y
MAVERICK CAPITAL LTD IVVD Invivyd, Inc. 13G 8.5% 2y
PRICE T ROWE ASSOCIATES INC /MD/ SG Sweetgreen, Inc. 13G/A 0% 2y
FIR TREE CAPITAL MANAGEMENT LP AFAR Aura FAT Projects Acquisition Corp Class A Ordinary Shares 13G 7.29% 2y
Atalaya Capital Management LP BYNO byNordic Acquisition Corp 13G/A 2.4% 2y
Sculptor Capital LP AAGR African Agriculture Holdings Inc. Common Stock 13G/A 0.45% 2y
Encompass Capital Advisors LLC OKLO Oklo Inc. 13G/A 9.26% 2y
ALLIANCEBERNSTEIN L.P. SFBC Sound Financial Bancorp, Inc. 13G 5.5% 2y
T. Rowe Price Investment Management, Inc. BFS Saul Centers, Inc. 13G 8.9% 2y
AQR CAPITAL MANAGEMENT LLC ESHA ESH Acquisition Corp. 13G 6.79% 2y
GLENVIEW CAPITAL MANAGEMENT, LLC DXC DXC Technology Co 13G/A 6.86% 2y
FIR TREE CAPITAL MANAGEMENT LP BLUA BlueRiver Acquisition Corp. 13G 7.44% 2y
CANNELL CAPITAL LLC NOA North American Construction Group Ltd. 13G/A 5.31% 2y
Morana Jovan-Embiricos CGEM Cullinan Therapeutics, Inc. 13G/A 5.09% 2y
Avoro Capital Advisors LLC KRYS Krystal Biotech, Inc. 13G/A 9.1% 2y
ISZO CAPITAL LP NTPIF Nam Tai Property Inc. 13G/A 18.6% 2y
Point72 Asset Management, L.P. LBPH Longboard Pharmaceuticals, Inc. Common Stock 13G/A 3.8% 2y
PERCEPTIVE ADVISORS LLC ACLX Arcellx, Inc. 13G/A 8.8% 2y
T. Rowe Price Investment Management, Inc. AEE Ameren Corp 13G 5.6% 2y
T. Rowe Price Investment Management, Inc. PRA Proassurance Corp 13G 8.2% 2y
William H. Armstrong III STRS Stratus Properties Inc 13G/A 7.45% 2y
ARMISTICE CAPITAL, LLC BKYI Bio Key International Inc 13G 9.99% 2y
ARISTEIA CAPITAL, L.L.C. SBXC SilverBox Corp III 13G 5.07% 2y
Gregory A. Demopulos, M.D. OMER Omeros Corp 13G/A 8.8% 2y
Conversant Capital LLC RPC Ridgepost Capital, Inc. 13G/A 2.4% 2y
Driehaus Capital Management LLC HRTG Heritage Insurance Holdings, Inc. 13G 6.33% 2y
Fourthstone LLC QNBC Qnb Corp. 13G 5.72% 2y
Centiva Capital, LP IVCA Investcorp AI Acquisition Corp. Class A Ordinary Share 13G 5.61% 2y
METEORA CAPITAL, LLC IVCA Investcorp AI Acquisition Corp. Class A Ordinary Share 13G 6.29% 2y
PRICE T ROWE ASSOCIATES INC /MD/ SRRK Scholar Rock Holding Corp 13G/A 12.3% 2y
G1 Execution Services, LLC MARA MARA Holdings, Inc. 13G/A 4.1% 2y
Craig F. Courtemanche, Jr. PCOR Procore Technologies, Inc. 13G/A 4.67% 2y
PRICE T ROWE ASSOCIATES INC /MD/ ROST Ross Stores, Inc. 13G/A 5.6% 2y
Fourthstone LLC FNWB First Northwest Bancorp 13G 9.86% 2y
PRICE T ROWE ASSOCIATES INC /MD/ SPHR Sphere Entertainment Co. 13G 6.1% 2y
Paul Packer CVU Cpi Aerostructures Inc 13G/A 8.6% 2y
MOORE CAPITAL MANAGEMENT, LP PARA Parabolic Technologies, Inc. 13G/A 1.8% 2y
COMPASS GROUP LLC GPRK GeoPark Ltd 13G/A 5.9% 2y
Point72 Asset Management, L.P. PRAX Praxis Precision Medicines, Inc. 13G/A 8.6% 2y
VIKING GLOBAL INVESTORS LP VVV Valvoline Inc 13G/A 2.4% 2y
Nantahala Capital Management, LLC FBIO Fortress Biotech, Inc. 13G/A 4.2% 2y
BIOTECHNOLOGY VALUE FUND L P CGEM Cullinan Therapeutics, Inc. 13G/A 9.99% 2y
Aristotle Capital Management, LLC ATO Atmos Energy Corp 13G/A 5.8% 2y
Brian E. Beasley BBGI Beasley Broadcast Group Inc 13G/A 9.7% 2y
PRICE T ROWE ASSOCIATES INC /MD/ RYN Rayonier Inc 13G/A 10.9% 2y
ADAMS STREET PARTNERS LLC MLYS Mineralys Therapeutics, Inc. 13G 5.6% 2y
PRICE T ROWE ASSOCIATES INC /MD/ LPRO Open Lending Corp 13G/A 8.9% 2y
Adit EdTech Sponsor, LLC GRDI GRIID Infrastructure Inc. Common Stock 13G/A 19.35% 2y